Calibrate

Calibrate is revolutionizing the approach to weight management with a focus on overall metabolic health and sustainable, long-term results. Established in 2020 and headquartered in the United States, Calibrate utilizes a clinician-guided and value-based outcomes model to integrate medication with transformative behavior change, significantly reducing the total cost of care for employers and payers. The company's commitment to innovation has garnered prestigious accolades, including recognition from the World Economic Forum’s Technology Pioneers, Fast Company’s World Changing Ideas, TIME’s Best Inventions, and the Employer Health Innovation Roundtable Traction Awards. Notably, Calibrate has secured backing from prominent healthcare investors such as Madryn Asset Management and Redesign Health, with the most recent Private Equity Round investment occurring on 01 November 2023. This strategic support underscores the confidence that leading industry players have in Calibrate's disruptive approach to addressing the challenges of obesity treatment and metabolic health.